Moreover, CD4+ iTregs can be induced in vitro from CD4+ Tconvs under specific culture conditions and these cells are currently being tested in clinical trials as potential autologous cell therapy for patients affected by several autoimmune diseases [17]. This evidence concerns the gene CD4 and autoimmune disease.